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Cyanobacteria (blue-green algae) produce toxins that may present a hazard for drinking water safety.
These toxins (microcystins, nodularins, saxitoxins, anatoxin-a, anatoxin-a(s), cylindrospermopsin) are
structurally diverse and their effects range from liver damage, including liver cancer, to
neurotoxicity. The occurrence of cyanobacteria and their toxins in water bodies used for the
production of drinking water poses a technical challenge for water utility managers. With respect to
their removal in water treatment procedures, of the more than 60 microcystin congeners,
microcystin-LR (L, L-leucine; R, L-arginine) is the best studied cyanobacterial toxin, whereas
information for the other toxins is largely lacking. In response to the growing concern about
nonlethal acute and chronic effects of microcystins, the World Health Organization has recently set
a new provisional guideline value for microcystin-LR of 1.0 pg/L drinking water. This will lead to
further efforts by water suppliers to develop effective treatment procedures to remove these
toxins. Of the water treatment procedures discussed in this review, chlorination, possibly micro-
/ultrafiltration, but especially ozonation are the most effective in destroying cyanobacteria and in
removing microcystins. However, these treatments may not be sufficient during bloom situations or
when a high organic load is present, and toxin levels should therefore be monitored during the
water treatment process. In order to perform an adequate human risk assessment of microcystin
exposure via drinking water, the issue of water treatment byproducts will have to be addressed in
the future. Key words: cyanobacteria, ozone, risk assessment, toxin, water treatment. - Environ
Health Perspect 108(suppl 1 :113-122 (2000).
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Toxic blue-green algae in water used as
drinking water or for recreational purposes
poses a hazard to humans but has long been
neglected or at most been treated on a local
level. Scums ofblue-green algae or cyanobac-
teria accumulating along the shores ofponds
and lakes also present a hazard to wild and
domestic animals. Providing the human pop-
ulation with safe drinking water is one ofthe
most important issues in public health and
will gain more importance in the coming mil-
lennium. Reports of toxic blooms and poi-
sonings ofhumans and cattle range from the
first report of a toxic Nodularia bloom in
Lake Alexandrina, Australia, in 1878 (1), to a
high incidence of primary liver cancer (PLC)
in China attributed to cyanobacterial toxin-
contaminated drinking water (2-4), to the
recent tragic deaths of60 dialysis patients in
Caruaru, Brazil, in 1996 due to the presence
of cyanobacterial toxins in the water supply
used in a hemodialysis unit (5,6). The pres-
ence of cyanobacterial toxins in drinking
water supplies poses a serious problem to
water treatment facilities, since not all techni-
cal procedures are able to effectively remove
these toxins to below acceptable levels.
Despite this, it is highly unlikely that lethal
poisonings would occur following consump-
tion of drinking water contaminated with
cyanobacterial toxins. Of much higher con-
cern are low-level chronic exposures, since the
risks associated with long-term exposure have
not been adequately described. Drinking
water suppliers are nevertheless confronted
with a variety ofquestions ranging from what
levels actually occur in the drinking water
sources to the current state of knowledge
about acute and chronic effects and effective
water treatment technologies in removing
toxins (7). This review addresses these issues.
Cyanobacteria
MorphologyandTaxonomy
Cyanobacteria are an ancient group of
organisms whose habitats range from hot
springs to temporarily frozen ponds in
Antarctica (8). They occur both in freshwater
and in marine environments. Cyanobacteria,
like eubacteria, lack a nucleus, whereas in con-
trast to their closest relatives, the purple and
the green sulfur bacteria, they produce oxygen
(9). According to the current taxonomy, 150
genera with about 2,000 species, at least 40 of
which are known to be toxicogenic, have been
identified (10). Cyanobacteria grow as single
cells, as single cells in colonies, or as single
cells in filaments, whereas some filamentous
genera contain special nitrogen-fixing hetero-
cysts. Cells growing in colonies may be packed
in a mucilaginous sheath like Microcystis sp.
or, in the case offilamentous species, grow as
floating mats or as free-floating strands. Many
cyanobacterial species possess gas vacuoles that
allow them to regulate their position in the
water column and give them a distinct ecologic
advantage over other planktonic species.
Bloom Formation
Prevention of bloom formation is the most
efficient method for avoiding cyanobacterial
toxin contamination of drinking water.
Unfortunately the factors leading to
cyanobacterial bloom development (cell
numbers > 106/L), whether of toxic or non-
toxic species, have not been satisfactorily
identified. Factors such as nitrogen, phos-
phorus, temperature, light, micronutrients
(iron, molybdenum), pH and alkalinity,
buoyancy, hydrologic and meteorologic
conditions, and the morphology of the
impoundment have all been implicated [for a
discussion see Chorus and Bartram (11)].
More importantly, factors influencing toxin
production have not been conclusively eluci-
dated (12). Although these factors can be
considered closely related to bloom forma-
tion, cell numbers and toxin levels are usually
not closely related. Furthermore, few general-
izations can be made from the few laboratory
studies that have been conducted to date
(7,13-16).
Cyanobacterial Toxins
Cyanobacteria produce a variety of toxins,
subsequently called cyanotoxins, that are
classified functionally into hepato-, neuro-,
and cytotoxins. Additionally, cyanobacteria
produce lipopolysaccharides (LPS) as well as
secondary metabolites that are potentially
pharmacologically useful. The former are
responsible for the irritant nature of
cyanobacterial material. Defined by their
chemical structure, cyanotoxins fall into
three groups: cyclic peptides (the hepatotox-
ins microcystins and nodularin), alkaloids
(the neurotoxins anatoxin and saxitoxins),
and LPS. The species most often implicated
with toxicity are Microcystis aeruginosa,
Planktothrix (= Oscillatoria) rubescens,
Aphanizomenonflos-aquae, Anabaenaflos-
aquae, Planktothrix agardhii, and Lyngbia
spp. (Table 1).
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Table 1.Toxicity ofcyanobacterial toxins.
Toxin
Microcystin-LR
Microcystin-LA
Microcystin-YR
Microcystin-RR
lD-Asp3]microcystin-LR
[D-Asp3]microcystin-RR
[Dha7]microcystin-LR
[(6Z)-Adda]microcystin-LR
[(6Z)-Addalmicrocystin-RR
Nodularin
[LD-Aspl]nodularin
l)6Z)-Adda3)nodularin
Anatoxin-a
Anatoxin-a(s)
Saxitoxin
Cylindrospermopsin
LD50(pg/kg,
ip, mouse) Organism
50 M. aeruginosa, Aph. flos-aquae, M. viridis
50 M. aeruginosa, M. viridis
70 M. aeruginosa, M. viridis
600 M. aeruginosa, Anabaenasp., M. viridis
50-300 M. aeruginosa, Aph. flos-aquae, M. viridis,
O. agardhii
250 0. agardhii, M. aeruginosa, Anabaenasp.
250 M. aeruginosa, Anabaenasp., 0. agardhii
> 1200 M. viridis
> 1200 M. viridis
50 N. spumigena
75 N. spumigena
>2000 N. spumigena
200-250 Aph. flos-aquae, Anabaenaspp., Oscillatoria
sp., Aphanizomenon sp., Cylindrospermum sp.
20 Aph. flos-aquae
10 Aph. flos-aquae, A. circinalis, Cylindrospermopsis
raciborskii, Lyngbya wollei
2000 C. raciborskii, Umezakia natans, Aph. ovalisporum
CyclicPeptides
Microcystins and nodularins are the most
widespread cyanotoxins. They can be found
in cyanobacterial blooms ranging from fresh-
water bodies to oceans. Microcystins have
been described from the genera Microcystis,
Anabaena, Planktothrix, Nostoc, and
Anabaenopsis, whereas nodularin has been
found only in Nodularia (17-21).
Toxin synthesis. Although the environ-
mental conditions under which cyanobacteria
produce toxins remain largely unknown, the
way these toxins are synthesized is becoming
clearer. Their small size, cyclic structure, and
content ofunusual amino acids indicate that
these peptides aresynthesized nonribosomally
rather than on ribosomes (22,23). The
enzymes involved in nonribosomal peptide
synthesis, peptide synthetases, have highly
conserved structures. The genes coding for
these peptide synthetases are modular, each
module containing information for a single
peptide synthetase unit. Using two conserved
sequence motifs of the adenylate-forming
domain ofpeptide synthetases to search for
homologous sequences in toxic and nontoxic
strains ofM. aeruginosa, it was found that
only the toxic strain contains peptide synthe-
sis gene sequences (23). The ability of a
cyanobacterial strain to produce toxins may
thus depend primarily on the possession of
these genes and on their expression under cer-
tain environmental conditions. With the
emergence ofa molecular genetics-based tax-
onomy ofcyanobacteria together with the
development ofpolymerase chain reaction
primers and DNA probes specific for toxic
strains ofcyanobacteria, these toxin-produc-
ing strains may be identified more rapidly in
the future (24-26).
Structure and uptake. These cyclic
peptides (Figure 1) are rather small molecules
with a molecular weight ranging from
Reference
(31,125)
(138)
(31)
(139-141)
(142,143)
(19,139)
(139,144)
(143)
(143)
(145)
(146)
(146)
(145,147)
(148)
(42,149)
(150)
800-1,000 Da (17,27). Most congeners are
hydrophilic and generally not able to pene-
trate vertebrate cell membranes and therefore
require uptake via an adenosine triphosphate
(ATP)-dependent transporter. One thus far
unidentified multispecific organic anion
transporter (or bile acid transporter) has been
described as the carrier ofthese cyclic pep-
tides in rat liver (28-30). As a result ofthis,
toxicity of microcystins and nodularins is
restricted to organs expressing the organic
anion transporter on their cell membranes,
such as the liver. The structure of the hep-
tapeptide microcystin was first identified in
1982 from an isolate of M. aeruginosa.
Meanwhile, about 60 congeners with the
general structure cyclo-(D-alaninel-X2-D-
MeAsp3-Z4-Adda5-D-glutamate6-Mdha7)
have been characterized (Table 1) (17,27,
31-33). X and Z are two variable L-amino
acids, D-MeAsp is D-erythro-f-methylaspartic
acid, and Mdha is N-methyldehydroalanine.
Adda is an unusual amino acid and unique to
cyanobacterial toxins: (2S, 3S, 8S, 9S)-3-
amino-9-methoxy-2,6,8-trimethyl- 10-
phenyldeca-4,6-dienoic acid. Nodularin is a
pentapeptide with the general structure
cyclo-(D-MeAspl-L-arginine2-Adda3-D-
glutamate4-Mdhb5). Mdhb is 2-(methyl-
amino)-2-dehydrobutyric acid. The most
common structural variants occur in positions
2 and 4, resulting in substitutions of the
L-amino acids, and demethylation ofamino
acids at positions 3 and/or 7. The current
nomenclature names the most common struc-
tural variation, i.e. microcystin-LR (L,
L-leucine; R, L-arginine) or microcystin-LW
(W, L-tryptophane) (34). 6Z-stereoisomers of
Adda have been reported for nodularin and
microcystin (Table 1). [(6Z)-Adda5]nodu-
larin, [(6Z)-Adda5]microcystin-LR, and
[(6Z)-Adda5]microcystin-RR have all been
reported to be nontoxic in the standard mouse
bioassay, with LD50 (median lethal dose)
values of> 1,200 pg/kgbodyweight (bw).
Cylindrospermopsin
Cylindrospermopsin (Figure 1) is a struc-
turally distinct toxin that has been found in
tropical and subtropical waters ofAustralia,
where it causes problems in water supplies
(35). This alkaloid cyto- and hepatotoxin is
produced mainly by Cylindrospermopsis raci-
borskii but also by Aph. ovalisporum and
Umezakia natans.
Neurotoxins
The neurotoxins (Figure 2) described in
cyanobacteria can be classified into three dis-
tinct groups: a) anatoxin-a and homoana-
toxin-a; b) anatoxin-a(s), which is structurally
not related to anatoxin; and c) saxitoxins or
paralytic shellfish poisons (PSPs). Anatoxin-a
has been described in A. flos-aquae and other
Anabaena spp., Planktothrix sp. (Oscillatoria
sp.), Aphanizomenonsp., Cylindrospermum sp.
and in small amounts even in Microcystis sp.
(33,36,37). Anatoxin-a exerts its neurotoxic
effect by mimicking acetylcholine with an
LD50 of200-250 pg/kg bw (36). Anatoxin-
a(s) is the only naturally occurring organo-
phosphate and has been isolated from A.
flos-aquae and A. lemmermannii (38). It is a
highly toxic compound with an LD50 of20
pg/kg bw (mouse ip) (39). Saxitoxins are
better known from marine dinoflagellates
(red tide) where they are responsible for par-
alytic shellfish poisoning after consumption
ofcontaminated shellfish. But saxitoxins, a
group of carbamate alkaloid neurotoxins,
have also been detected in relevant amounts
in freshwater cyanobacteria such as Aph.fibs-
aquae, A. circinalis, C. raciborskii, and
Lyngbya wollei(40-42).
Microcystins
AnimalToxicity
Since the first description in 1878 of a
Nodularia spumigena bloom in Lake
Alexandrina, Australia (1), numerous cases of
animal poisonings have been reported (Table
2). Most commonly, deaths offarm animals
drinking scums ofcyanobacterially contami-
nated ponds or poisonings ofdogs swimming
in cyanobacterial scum have been described
(7). Fish kills have been reported in conjunc-
tion with cyanobacterial blooms and have
often resulted in significant economic losses
(43-47). The liver is the major target organ
for microcystin toxicity; it was shown to accu-
mulate 20-70% of a radioactively labeled
toxin dose (intravenous) (48-54). Studies in
mice and pigs exposed to extracts ofa toxic
M. aeruginosa bloom demonstrated dose-
dependent toxicity (55,56). Increased mortal-
ity, liver weight, and plasma alanine
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aminotransferase levels were associated with
loss ofbody weight. Neither other organ sys-
tems nor lactate dehydrogenase levels were
affected. Death ofthe organism through intra-
hepatic hemorrhage and shock is rapid, occur-
ring within about 3 hr in the case ofmice.
Pathologic and ultrastructural features com-
monly observed in the liver are centrilobular
hepatic necrosis, destruction of sinusoidal
endothelium, disruption ofbile canalicular
function, intrahepatic hemorrhage, loss of
microvilli and bleb formation in hepatocytes,
andhepatocyte necrosis (29,57-61).
Inhibition ofProteinPhosphatases 1
and2A
The toxicity ofmicrocystins and nodularins is
due to inhibition ofthe catalytic subunit of
protein phosphatases 1 and 2A (PP1, PP2A)
(62-64). In the case of microcystins it has
been suggested that covalent binding to cys-
teine-273 and cysteine-266 on PPI and
PP2A, respectively, is responsible for this
effect (65,66). PP1 and PP2A dephosphory-
late phosphoseryl or phosphothreonyl
proteins and their inhibition leads to hyper-
phosphorylation of cytoskeletal proteins
resulting in the deformation ofhepatocytes
(28,67-71). It is not clear, however, ifthe
covalent binding ofthe toxin to PP1 or PP2A
is in fact responsible for the inactivation,
since inactivation precedes covalent modifica-
tion and nodularin does not bind covalently
(72). Furthermore, it has been suggested that
the Adda side chain and possibly the planar
ring portion of the peptide are responsible
for both recognizing and inhibiting protein
phosphatases (73,74).
Glu Mdha
CO2H
Adda
OCH3
CH3
Ala
CH3
0 HO2C
Microcystin-LR
Arg
NH=i
Leu
Masp
TumorPromotion
The cyanobacterial cyclic peptides possess
tumor-promoting activity (TPA) by a TPA-
independent pathway (75). Cyanobacterial
extracts or microcystin-LR in drinking water
induce skin tumors in rats and mice after ini-
tiation with 7,12-dimethylbenz[a]anthrazene
(76,77). Glutathione-S-transferase placental
form positive foci were detected in livers of
rats after ip injection of microcystin-LR or
nodularin and initiation with diethyl-
nitrosamine (78-80). It has been speculated
that these toxins may be liver carcinogens,
since they induce foci or small neoplastic
nodules without the use ofinitiators (80,81).
Both microcystin-LR and nodularin induce
the expression oftumor necrosis factor-cc and
early response genes (c-jun,jun B, jun D,
c-fos,fos B,fra-1) in rat liver and hepatocytes
(80,82). In addition, mutations in the K-ras
codon 12 in the RSa cell line (83) and DNA
fragmentations have been reported after ip
injection ofcyanobacterial extract or micro-
cystin-LR in mice (84,85). These in vitro and
H
o
N
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8
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Anatoxin-a
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Nodularin
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Figure 1. Structure of microcystin, nodularin, and cylindrospermopsin.
R = H; saxitoxin dihydrochloride
R = OH; neosaxitoxin dihydrochloride
/ S~~~ \ / ~CH3 HN3 5 N
N\
>0
+H2N CH
0
Anatoxin-a(s)
Figure 2. Structure of anatoxin-a, saxitoxins, and
anatoxin-a(s).
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Table 2. Toxic cyanobacteria episodes.
Location Year Case Organism Toxin Reference
Lake Alexandrina, Australia 1878 Livestock stupor Nodularia spumigena Nodularina (1)
Ohio River, U.S. 1931 Humans: gastroenteritis Unspecified cyanobacteria Unknown (86)
Harare, Zimbabwe 1966 Humans: gastroenteritis Microcystis aeruginosa Unknown (87)
Alpine Lakes, Switzerland 1974-1994 Cattle deaths, liver damage Oscillatoria limosa, 0. tenuis, Phormidium PPI-toxinb (151)
sp., Tychonemasp., Pseudoanabaena
catenata, P. autumnalea.o.
Armidale, Australia 1983 Humans: liverdamage Microcystisaeruginosa Unknown (88)
Palm Island, Australia 1983 Humans: hepatoenteritis Cylindrospermopsis raciborskii Cylindrospermopsin (152)
Richmond Lake, U.S. 1988 Livestock, birds, dogs, fish Anabaena flos-aquae, Aphanizomenon Anatoxin-a(s) (153)
flos-aquae, Microcystis aeruginosa
Rudyard Reservoir, U.K. 1989 Humans: recruits, pneumonia, diarrhea Microcystisaeruginosa Microcystin-LR (154)
Darling River, Australia 1990-1991 Livestock deaths Anabaena circinalis Saxitoxin (42)
1000-km bloom Neosaxitoxin
Loch lnsh, Scotland, U.K. 1992 Dog death Oscillatoria sp. Anatoxin-a (155)
Itaparica Dam, Brazil 1993 Humans: 88 deaths, gastroenteritis Anabaenasp., Microcystissp. Unknown (89)
Loch Leven, Scotland, U.K. 1994 Fish deaths Anabaena flos-aquae Microcystin (44)
Nandong District, Jiangsu Province, 1994-1995 Humans: PLC 100 of 105toxins act M. aeruginosa, Planktothrixagardhii, Microcystins (156)
Nanhui/Shanghai, Fusui, China with HBsAg and aflatoxin Anabaenasp., 0. tenuis, Lyngbyasp. (2-4)
Caruaru, Brazil 1996 Hemodialysis patients: 60 deaths Aphanizomenon sp., Oscillatoriasp. Microcystins (5,6)
Abbreviations: HBsAg, hepatitis Bantigen; PLC, primary livercancer; PPI, protein phosphatase inhibition.&Suspected. bProtein phosphatase-inhibiting activity.
in vivo data have to be viewed in the light of
observations in China, where consumption of
microcystin-contaminated drinking water has
been associated with a high incidence ofPLC
(2-4) (see next section).
Human Healdth Effects
Evidence ofhuman poisonings by cyanobac-
terial toxins ranges from health effects after
recreational exposure to poisonings following
consumption ofcontaminated drinking water
(Table 2).
Acute and subchronic exposures. The
earliest case ofgastroenteritis from cyanobac-
teria was reported in 1931 in towns along the
Ohio River, where low rainfall had caused the
development ofa large cyanobacterial bloom
(86). The water treatment procedures
employed over months to combat this bloom
(prechlorination, sedimentation, filtration,
chlorination, copper sulfate to lyse the
cyanobacterial cells, aeration, activated car-
bon, permanganate, ammonia, and dechlori-
nation) all proved to be ineffective in
reducing taste, odor, or toxin content ofthe
drinking water. A natural Microcystis bloom
in a water reservoir in Harare, Zimbabwe,
caused gastroenteritis in children each year
when the bloom was decaying (87). A partic-
ularly extensive and toxic (microcystin-YM
[Y, L-tyrosine; M, L-methionine]) (31) M.
aeruginosa bloom in Malpas Dam, near
Armidale, Australia, was treated with copper
sulfate in 1981 after complaints ofbad taste
in the drinkingwater were received (88). The
plant treating the water used prechlorination,
alum flocculation, sedimentation, rapid sand
filtration, postchlorination, and fluoridation.
The effect ofthis toxic bloom event was then
monitored in a retrospective epidemiologic
study of liver function in the population
consuming the water. It was found that the
serum level ofthe liver enzyme y-glutamyl-
transferase was elevated in that part ofthe
population using the Malpas Dam water dur-
ing the bloom and after the bloom was lysed
with copper sulfate. The two most lethal poi-
sonings attributed to cyanobacteria in drink-
ing water occurred in Brazil. A massive
Anabaena and Microcystis bloom in Itaparica
Dam was responsible for 2,000 gastroenteritis
cases resulting in 88 deaths, mostly children
(89). A very tragic though relatively well-
documented case occurred in a hemodialysis
center in Caruaru in 1996 (5,6). The water
used in the dialysis unit, taken from Tabocas
Reservoir, was normally sedimented with
alum, filtered, and chlorinated in the munici-
pal water treatment plant prior to being sup-
plied by truck to the clinic. At the dialysis
unit, the waterwas furtherpurified by passing
through sand, charcoal, and an ion-exchange
resin, and finally by micropore filtration.
During the 1996 summer drought, the dialy-
sis center received water from the municipal
plant that was only treated with alum, but
not filtered or chlorinated. There are conflict-
ing reports as to whether the water was chlo-
rinated in the trucks prior to delivery to the
clinic. Furthermore, the charcoal, sand, and
micropore filters at the clinic had not been
changed in the 3 months prior to this
episode, even though the water received from
the trucks had been visibly turbid. In
February 1996, the majority (85%) of the
hemodialysis patients developed a toxic illness
ofvarying severity, with a wide range ofneu-
rologic symptoms as well as acute liver injury.
Up to 23 patients died in the first 2 weeks of
this episode with either neurologic symptoms
or from liver failure. About 37 more patients
died in the following 5 weeks either directly
from hepatotoxic effects or from complications
such as sepsis, gastrointestinal bleeding, or
cardiovascular effects. The patients displayed
cholestatic jaundice with high bilirubin and
alkaline phosphatase concentrations, and
increases in hepatic enzymes (aspartate and
alanine aminotransferase). Liver pathology
showed the presence ofan acute novel toxic
hepatitis similar to that seen in animals
exposed to microcystins (6). Histopathology
showed panlobular hepatocyte necrosis,
together with cell-plate disruption and apop-
tosis. However, in contrast to animal models
of microcystin intoxication, no intrahepatic
hemorrhage could be observed. After initial
uncertainties as to the causative agents of
these fatal intoxications, microcystin concen-
trations were determined in serum and in
liver tissue as well as in the water filtration
columns. The latter contained intact and
fragmented cyanobacterial cells as well as
microcystin-LR. Levels in serum ranged from
1 to 10 ng/mL; concentrations in the liver
were as high as 0.6 mg/kg tissue. Toxin con-
geners were reported to be microcystin-YR,
microcystin-LR, and microcystin-AR (A,
L-alanine). At the time of the outbreak,
cyanobacterial counts had not been made in
the reservoir, but in March 1996, it was
found that the most common cyanobacterial
genera present were Aphanizomenon,
Oscillatoria, and Spirulina.
Chronic exposure. When considering the
chronic effects of long-term exposure to
microcystins in drinking water, one has to
take into account the high incidences ofPLC
in regions of China where pond and ditch
water are used as drinking water supplies. In
Haimen and Qidong (Jiangsu Province),
pond and ditch water used as drinking water
showed average microcystin concentrations of
160 pg/mL (60% of the samples analyzed
were positive), whereas microcystins could
not be detected in well water (2-4). PLC
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incidences of4.28 per 100,000 and 100.13
per 100,000 were observed in humans using
well water and pond/ditch water, respectively
(2). It has been calculated that humans living
in areas with a reported high PLC incidence
consume 0.19 pg microcystin per day during
the 4 summer months from June to
September over their 40- to 50-year life span
(4). Coexposure to the potent liver carcino-
gen aflatoxin B1 or to hepatitis B virus may
result in the high incidence of PLC in this
region (4).
Efficacy ofWaterTreatment
Procedures
Water treatment measures should always be
just one option after other techniques such as
selection ofintake depth, offtake by bank fil-
tration, and/or use ofbarriers to restrict scum
movement have been used. When evaluating
water treatment procedures for the removal of
cyanobacterial toxins, one is faced with prob-
lems regarding soluble and suspended sub-
stances. Cyanotoxins are produced within the
cyanobacterial cells and thus toxin removal
involves measures to destroy or avoid the
cells. The cyanotoxins also are all water solu-
ble, thus remediation measures involve chem-
ical procedures reducing the toxicity or
completely removing the toxins from the
drinkingwater.
Most studies, especially early ones, had to
rely on relatively crude measurements of
acute toxicity, since more specific analytical
methods were not available. The cyclic hep-
tapeptides have been the focus of most of
these studies, but some studies on removal of
saxitoxins and anatoxin-a also exist.
Coagulaton/Flocculation, Dissolved
Air Flotation, andActivatedCarbon
Adsorption
Coagulation or flocculation involves the
aggregation ofsmaller particles into larger par-
ticles using chemicals such as ferric chloride or
aluminum sulfate. Coagulation can be an effi-
cient method for eliminating cyanobacterial
cells from water, whereas soluble cyanotoxins
are not very efficiently removed by this
method (90,91). The efficiency ofcyanobac-
terial removal is dependent on an optimiza-
tion ofchemical doses and coagulation pH
(92). Coagulation may cause additional prob-
lems such as lysing ofcyanobacterial cells lead-
ing to release oftoxins (90). When employing
dissolved air flotation (DAF), it is important
to consider that different cyanobacterial
species behave differently depending on their
physical properties: in a Belgian DAF plant
Microcystis was removed by 40-80%,
Anabaenaby 90-100%, but Planktothrixonly
by 30% (93). Because conventional water
treatment usually involves a combination of
these methods, most of the research has
focused on the effect ofcoagulation/floccula-
tion in combination with other measures. In
one ofthe earliest studies, toxins isolated from
algal material were subjected to a) activated
carbon filtration; b) prechlorination, floccula-
tion with FeCI3, sedimentation, sand filtra-
tion, and activated carbon filtration; and
c) lime pretreatment, flocculation with FeCl3,
chlorination, and activated carbon filtration
(94). The toxicity ofthese samples was then
tested in the mouse bioassay. Chlorination,
flocculation, or sand filtration were unable to
destroy the toxins; only the last step, pow-
dered activated carbon (PAC) at a ratio of
1:10 to 1:100 (toxin:activated carbon),
removed a toxin concentration of3 pg/mL to
below toxic levels. Studies using 50 mg
lyophilized cyanobacteria also show that con-
ventional flocculation, filtration, and chlorina-
tion are not efficient in destroying the toxins:
high performance liquid chromatography
(HPLC) analysis shows a toxin reduction of
up to only 34% (95,96). Only the inclusion
of a treatment step with activated carbon
resulted in 100% removal ofthe toxins from
water. On the basis ofthe results ofthese lab-
oratory studies, Lahti and Hiisvirta (97) con-
ducted pilot-scale experiments to study the
feasibility of predicting the behavior of
cyanobacterial toxins in water treatment prac-
tice. Both fresh and freeze-dried cyanobacteria
were subjected to the following processes: a)
flocculation withA12(S04) plus sedimentation
plus filtration, and b) PAC plus flocculation
with A12(S04) plus sedimentation plus filtra-
tion. Toxicity was measured using the mouse
bioassay and HPLC. As was to be expected
from the laboratory scale studies, only the
inclusion ofPAC significantly reduced toxic-
ity. Activated carbon is, however, not always a
very efficient method. A study aimed at the
removal ofcyanobacterial cells with rapidsand
filtration and activated carbon found a reduc-
tion ofcyanobacteria ofonly 42% (98). More
detailed studies with activated carbon show
that both PAC as well as granular-activated
carbon (GAC) effectively and quickly (contact
times of30 min are sufficient) eliminate cyan-
otoxins from water (99-101). In the case of
PAC, dosing is an important parameter (10
pg/L toxin: > 200 mg/PAC/L), whereas when
using GAC, the choice ofthe carbon source is
important (coal, wood > peat, coconut),
probably due to the different pore sizes rela-
tive to the size of the microcystin molecule
(102). A major concern when using activated
carbon in water treatment plants is the forma-
tion of a biofilm, which can significantly
impair the ability ofthe filter to adsorb tox-
ins; biodegradation by the biofilm does not
seem to occur (99,103,104). Furthermore,
below concentrations of0.15 pg microcystin-
LR/L, very little microcystin will be removed
by activated carbon in the presence of a
biofilm or natural organic matter (103). This
finding has consequences for the risk
assessment of a chronic exposure to low
microcystin concentrations.
RapidFiltrationandSlowSand
Filtraion
The performance ofrapid filtration, a method
usually employed after coagulation to remove
the floc, does not effectively remove cyanobac-
terial cells (98,105). Conventional water treat-
ment requires regular backwashing of the
filters, but ifthis washing process is performed
inadequately, lysis ofcyanobacterial cells on
the filters can lead to release of toxins into
the water (11,106). Furthermore, sand filtra-
tion alone does not lead to substantial reduc-
tion oftoxicity (99), and blocking caused by
overloading should be avoided (11).
Chlorinatinon
In general, chlorination is not an effective
process in destroying cyanotoxins (94-96,
107). The efficiency ofchlorination seems to
depend largely on the chloride compounds
and the concentration used. Aqueous chlorine
and calcium hypochlorite at. 1 mg/L remove
more than 95% ofmicrocystins or nodularin,
while sodium hypochlorite at the same dose or
chloramine achieve 40-80% removal at most
(91,108,109). A chlorine residual ofat least
0.5 mg/L should be present after 30 min con-
tact time in order to destroy cyclic peptides
completely (110). It should be noted, how-
ever, that even when acute toxicity, as mea-
sured by the mouse bioassay, was removed by
this process, progressive liver damage could
still be detected in the animals. This subacute
toxicity may be due to incomplete toxin
removal or to the formation ofchlorination
byproducts, which have been implicated in
toxicity (111). Anatoxin-a or saxitoxins could
neither be destroyed with chlorine doses
exceeding a 30-min chlorine demand nor
by changes in pH (107,108). Cylindro-
spermopsin, on the otherhand, was effectively
oxidized by 4 mg/L chlorine at pH 7.2-7.4
(toxin concentration 20-24 pg/L) (108).
Light
Microcystins are verystable under natural sun-
light (112), whereas ultraviolet (UV) light
around the absorption maxima ofmicrocystin-
LR and microcystin-RR rapidly decomposed
the toxins (113). A photocatalytic process
using a TiO2 catalyst and UV radiation also
quicklydecomposed microcystin-LR, -YR, and
.YAwith half-lives of< 5 min (114). The effi-
ciencyofthis process was largelydependent on
the organic load ofthe water (114).
Membrane Processes
Microfiltration (MF) and ultrafiltration (UF)
are technologies that have emerged in recent
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years and have therefore not been thoroughly
investigated as to their efficiency in removing
cyanobacterial cells or toxins (7). One study
showed that both UF and MF can be very
efficient (> 98%) in removing whole cells of
toxic M. aeruginosa (115). An important
point when considering filtration is the lysis
ofcells. In the case ofthe above-cited study,
some damage to cells could be observed, but
toxin was not detected in the filtrate. UF was
also effective in reducing microcystin and
nodularin levels in the filtrate. This may be
expected from a membrane with a very
low-molecular-weight cut-off pore size
(nanofiltration membrane) (101,116).
Ozonation
In Europe and North America, ozonation has
been used primarily for disinfection purposes
or to remove color and/or odor (117). Ozone
was initially used at the beginningofthe water
treatment train mainly to inactivate viruses
and bacteria. In recent years, though, many
water treatment plants have included a two-
stage ozonation treatment, either with pre-
and interozonation, inter- and postozonation,
orwith pre- and postozonation.
In water, two pathways for the oxidation
of organic pollutants by ozone have been
described (117,118): direct attack by mole-
cular ozone via cycloaddition or elec-
trophilic reaction, and indirect attack by
free radicals (primarily OH) formed by the
decomposition of ozone. The mechanism
involving cycloaddition in water usually
results in the formation of aldehydes, car-
boxylic acids, ketones, and/or carbon diox-
ide. The electrophilic attack by molecular
ozone probably occurs on atoms carrying
negative charge such as N, P, 0, or nucle-
ophilic C. An indirect attack by free radicals
generally occurs via one of three pathways:
hydrogen abstraction, electron transfer, or
radical addition.
Microcystins andnodularin. Ozone is one
ofthe most powerful oxidizing agents and its
potential to destroy cyanobacterial toxins has
been investigated in the last 10years (Table 3).
In one ofthe earliest studies looking at the
effect ofozone on cyanotoxins, researchers at
the British Foundation for Water Research
ozonated microcystin-LR purified from M.
aeruginosa and assessed toxicity using a mouse
bioassay (90,119). After ozonation, the toxic-
ity ofthe cyanotoxin is reduced, which could
be shown by a prolongation ofmouse survival
time, but the results cannot be quantified
since the authors omitted to detail ozone or
toxin concentrations. HPLC and fast atom
bombardment-mass spectrometry analysis also
show a reduction in the microcystin peak after
a 2-sec ozonation. Interestingly, several new
peaks appeared but were not tested separately
for toxicity. This very fast destruction of
microcystin was corroborated in Australian
studies quantifying the effect ofozone on dif-
ferent microcystin-LR concentrations
(91,108,120) and in our own work (121).
These studies showed that up to 800 pg/L
microcystin-LR can be oxidized to below the
HPLC detection limit by < 0.2 mg/L ozone
within seconds to minutes. The reaction of
ozone with nodularin also occurs very rapidly:
when reacting 88 pg/L nodularin with 0.05
mg/03, there was zero toxin recovery after 15
sec (120). With these studies it was also
demonstrated that the removal ofmicrocystins
is proportional to the ozone dose when the
microcystin concentration is below the ozone
demand (91). Complete removal of micro-
cystin is achieved and an ozone residual is
detected when the ozone demand ofthe water
has been met.
Cyanobacterial extracts and cells and
organic load. Obviously, a more realistic way
to test the efficiency ofozonation would be to
use either cyanobacterial extracts or whole
cells (Table 4). Oxidation reactions ofozone
with cyanobacterial toxins are always in com-
petition with other organic compounds in the
water. As a result, naturally occurring organic
matter is one ofthe most important factors to
consider in terms of toxin dynamics. In a
study designed to model continuous opera-
tion, ozone doses from 1 to 10 mg/L were
tested over 5-10 min for their ability to
degrade 10 pg/L microcystin added to differ-
ent water sources (101). Two milligrams per
liter ozone added to raw water leads to a 60%
removal of microcystin, whereas the same
dose added to treated water removes toxins by
98%. A similar ozone demand was measured
in a study; 500 pg/L microcystin-LR was oxi-
dized with 0.2 mg/L 03 over 4 min in
organic-free water (122). The author calcu-
lated an ozone demand of 0.6 mg/L with
almost complete microcystin removal.
However, only 50% ofthe same microcystin
concentration was removed when filtered
Seine River (France) water was oxidized with
0.5 mg/L 03 over 10 min. This led to a
much higher ozone demand of 1.6 mg/L.
Our own results show that cyanobacterial
extracts (M aeruginosa or P. rubescens) con-
taining 50-100 ,ug/L microcystin-LR-equiva-
lents need to be oxidized with at least 1.0 mg
03/L to effectively destroy the toxins present,
whereas ozone residuals were undetectable
after 10 min (106). These results show that
ozone consumption by natural organic matter
still occurs at the preozonation stage. During
postozonation, 1 mg/L 03 removed 38% of
the microcystin, whereas > 2 mg/L 03
removed toxin related toxicity below the limit
ofdetection. The importance oforganic load
and ozone concentration was also demon-
strated in Australian studies: cyanobacterial
extracts containing 135-220 pg/L micro-
cystin-LR required 1.0 mg/L ozone over 5
min for complete toxin destruction
(108,120). After this treatment, the ozone
residual was zero, reflecting the higher
organic load and resultant high ozone
demand. The critical importance of ozone
dose, especially with respect to the organic
load ofthe water, was also shown in several
Finnish studies (95-97). Fresh and freeze-
dried natural bloom material (M aeruginosa,
M. wesenbergii, M. viridis) from a Finnish
lake (LD50 60-75 mg/kg bw, mouse ip) as
Table 3. Effect of ozone on destruction ofcyanobacterial toxins in the presence orabsence of organic matter.
Microcystin-LR Ozone dose Duration OM Destruction Ozone demand Ozone residual
(pg/L) (mg/L) (min) present (%) (mg/L) (mg/L) Reference
21 1.2 5 - 73 ND 0.13 (101)
9 1.0 5 + 50 ND 0 (101)
500 0.2 4 - 99 0.6 (122)
500 0.5 10 + 50 1.6 (122)
< 200 1.0 5 - 100 ND 0 (108,120)
15 1.0-1.5 30 + 50 ND ND (95-97)
50 1.0-1.5 30 + 90 ND ND (95-97)
10 0.5-1.5 9 - 90-100 ND 0.4-1.2 (121)
50-100 0.5-1.5 9 + 0-100 ND 0.1-0.6 (121)
ND, notdetermined; OM, organic matter.
Table4. Effect ofozone on destruction ofcyanobacterial toxinsfrom cells inthe presence orabsence oforganic matter.
Microcystis Ozone Ozone Ozone
aeruginosa dose Duration Destruction demand residual
(cells/mL) (mg/L) (min) (%) )mg) (mg/L) Reference
1.63 x 106 3.7 5 36 ND 0 (120)
2.05 x 106 2.5 12 100 29 ND (120)
1 x 104 0.8 10 60 ND 0.01 (107)
1xi05a 1.3 10 65 ND 0 (107)
1 x 105 1.0-1.5 9 50-100 ND 0.25-1.4 (106)
5 x 105 1.0-1.5 9 30-75 ND 0.4-0.8 (106)
ND, not determined.5In raw water; all otherexperiments in pure orfiltered water.
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well as a laboratory culture of P. agardhii
(NIVA-CYA 126; LD50 190 mg/kg bw,
mouse ip) were used. In a pilot plant setup, 35
mg/L fresh (50 jig/L toxin) or 24 mg/L (15
,ug/L toxin) freeze-dried cyanobacteria were
subjected to preozonation at a dose of 1.0-1.5
mg 03/L. This treatment resulted in a reduc-
tion oftoxicityby 50% (freeze-dried) and 90%
(fresh). As can be seen, toxin reduction from
fresh cyanobacteria was better than from
freeze-dried material. This may be explained
by the improved coagulation caused by preo-
zonation. Preozonation has been widely used
to assist coagulation (117). The major prob-
lem associated with this method is the danger
ofcell lysis and toxin release. A second posto-
zonation step, using an ozone concentration
high enough to oxidize the remaining organic
matter and toxin, would then be essential. The
experiment with freeze-dried material corre-
sponds to a situation where the bloom disinte-
grates and cells lyse due to chemical treatment
or as a result ofnatural causes. Preozonation
with 0.5-1.0 mg 03/L in that case is not the
most effective treatment. Postozonation is a
preferred method, since more ofthe oxidation
capacity could be used on toxins instead ofon
other organic material. A common problem
with these early studies is, however, that toxic-
ity was determined by the mouse bioassay
(detection in the microgram range) or by
HPLC (detection in the nanogram-microgram
range), two relatively insensitive assays (123).
Ozonation of intact cells during pre-
ozonation steps poses the riskofcyanobacterial
lysis and increased ozone demand. Ifcyano-
bacteria are not monitored at the water intake
level and thus enter the water treatment
process, the treatment plant may not be pre-
pared to meet the increased ozone demand.
This leads to either an increase in the soluble
toxin concentration in the water and/or to
incomplete degradation ofthe cyanotoxins.
Simulating bloom situations, studies were per-
formed with M. aeruginosa concentrations
from 1 x 104 to 2 x 106 cells/mL (107,120)
(Table 4). Depending on cell number and
organic load ofthe spiked water, an ozone
demand between 2 and 3 mg/L (over 5 min)
and 29 mg/L (over 12 min) was calculated.
This ozone demand is relatively high consider-
ing that water treatment plants regularly
employ a concentration of0.5 mg/L at preo-
zonation and 1.0 mg/L at postozonation
stages, respectively. This can also be seen in
our own study where ozonation with 1.0
mg/L 03 did not completely destroy the tox-
ins present in 1 x 105 cells/mL (106) (Table
4). Furthermore, when a culture of1.63 x 106
M aeruginosa cells/mL was ozonated with a
maximum of3.7 mg 03/L, only 36% oftotal
toxinwas removed after 5 min (120).
Anatoxin-a, anatoxin-a(s), andsaxitoxins.
The efficiency ofoxidation with ozone with
respect to anatoxin-a, anatoxin-a(s), or the
saxitoxins (PSPs) has not been well character-
ized (95,97). Using raw and filtered waters,
the British Foundation for Water Research
determined that anatoxin-a is more resistant
to removal by ozone than microcystin-LR
(107). The maximal ozone dose applied (4.5
mg/L) in raw water reduces the anatoxin-a
concentration from 2.4 pg/L to 0.6 pg/L,
whereas no ozone residual could be detected.
In filtered water, without competition from
natural organic material, 2.2 mg/L 03
destroys an anatoxin-a concentration to
below the limit ofdetection (0.3 jig/L). But
again, no ozone residual could be detected.
The PSPs require even higher 03 doses.
Ozonation over 15 min at 4.2 mg/min was
necessary to reduce the neurotoxicity of an
A. circinalis extract to near the lethal threshold
concentration (120). After 30 min ozonation,
the mice survived the doses. There are indica-
tions that other PSP toxins, such as GTX2,
dcGTX2, dcGTX3, C1, and C2, may also be
effectively oxidized by ozone (110). These
studies stress the need for more detailed and
quantifiable studies regarding the efficiency of
ozone in destroying the neurotoxins.
pH. Avery important parameter in the oxi-
dation efficiency ofozone is pH. At pH values
> 7.5, toxins can still be detected in the sam-
ples. This is due to the lower oxidation poten-
tial ofozone under alkaline conditions (1.24V)
compared to acidicconditions (2.07V).
Ozonation byproducts. In contrast to
chlorination byproducts, the issue ofozonation
byproducts has not been properly addressed.
One has to keep in mind though, that the
amount ofozone applied is always less than
what would be required to oxidize all the
organic material to CO2 and H20, especially
in water high with organic content. One can
therefore expect semioxidation products to
form (124). Such oxidation products were
found by HPLC when cyanobacteria were pre-
ozonated. Their toxicity was, however, not
investigated (97). Our work points to ozona-
tion products that still exhibit phosphatase
inhibitory activity, but their structure has not
yet been determined (121). An indication of
the effect ofozone on microcystins stems from
chemical characterization studies, since ozonol-
ysis has been widely employed for structural
characterization oforganic compounds by
cleavage of carbon-carbon double bonds
(125,126). In the case ofmicrocystins and
nodularin, ozonolysis has been applied in the
determination ofthe absolute configurations of
the Adda moiety (126). It has been described
that the double bond between C-6 and C-7 of
the Adda side chain is easily cleaved by ozone
to give 3-methoxy-2-methyl-4-phenylbutyric
acid. In order to realistically assess the con-
sequences of ozonation on cyanobacterial
toxins, the ozonation byproducts have to be
identified and their toxicity tested not only in
acute tests but also in subacute tests such as
the phosphatase inhibition assay as well as in
chronic situations.
Risk Assessment
The health risk posed by exposure to cyano-
toxins is difficult to quantify, since the actual
exposure and resulting effects have still not
been conclusively determined, especially for
the human situation. The most likely route for
human exposure is the oral route via drinking
water (127,128), recreational use oflakes and
rivers (129), or consumption ofalgal health
food tablets (130). The dermal route may
play a role during the recreational use ofwater
bodies (swimming, canoeing, etc.) (127,128).
Due to the growing concern about health
effects ofcyanotoxins, especially via drinking
water, the World Health Organization
(WHO) has adopted a provisional guideline
value for microcystin-LR of 1.0 jig/L in 1998
(131). This guidelinevalue is based on a toler-
able daily intake (TDI) value derived from
two animal studies (56,132). The first study is
a 13-week mouse oral study that determined a
no-observable adverse effect level (NOAEL) of
40 jg/kg bw per day based on serum enzyme
levels and liver histopathology (132).
Applying a total uncertainty factor of 1,000
(10 for intra- and interspecies variability,
respectively, and 10 for limitations in the
database, especially lack ofdata on chronic
toxicity and carcinogenicity), a provisional
TDI of 0.04 pg/kg bw per day has been
derived for microcystin-LR. This TDI was
supported by a 44-day pig oral study that
determined a lowest observable adverse effect
level (LOAEL) of 100 jig microcystin-LR
equivalents/kg bw per day (56). In this study,
the cyanobacterial material fed to the pigs
contained several microcystin congeners, but
only microcystin-YR was tentatively identi-
fied. To this LOAEL a total uncertainty factor
of 1,500 was applied (10 for intraspecies vari-
ability, 3 for interspecies variability, 5 for
extrapolating from a LOAEL to a NOAEL,
and 10 for the less-than-lifetime exposure).
This resulted in a provisional TDI of0.067
pg/kg bw per day. WHO used the lower of
these two values for establishing the provi-
sional guideline value. This value is calculated
by applying the TDI (0.04 pg/kg bw) to a
typical dailywater intake in liters (L = 2 liters)
by an individual ofa given bodyweight (bw =
60 kg) and a proportion (P= 0.8) ofthe total
daily intake to the intake bydrinkingwater:
Guideline value - TDIxbwxP
L
The resulting value of 0.96 pg/L was
rounded to 1.0 uig/L and should be applied to
cyanobacterial cell-bound and extracellular
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microcystins. This provisional guideline value
is applicable only for microcystin-LR, since
the database for other microcystin congeners
or even other cyanotoxins such as the saxitox-
ins is too small to derive a TDI. Health
Canada is applying an uncertainty factor of
3,000 to the NOAEL of40 pg/kg bw per day
from the 13-week mouse study by adding a
factor of3 for evidence oftumor promotion
and weak evidence ofa potential for carcino-
genicity in humans (133). They thus derive a
TDI of0.013 pg/kgbw perdayand conclude
that the consumption of 1.5 L drinking water
containing < 0.5 pg microcystin-LR/L by a
60-kg person would not exceed this TDI.
This discussion ofthe WHO guideline value
opens many questions for operators ofwater
treatment plants. Because the guideline value
is really only valid for microcystin-LR, in sit-
uations where it is not the most dominant
congener or not even present, the evaluation
ofquantitative measurements with respect to
the guideline may be problematic. This is
true for HPLC analysis as well as for the
mouse bioassay and the protein phosphatase
inhibition assay (11). Results should thus
always be reported with these points in mind
and should, ifpossible, be reported for micro-
cystin-LR concentration equivalents or toxic-
ity equivalents. The next question that
obviously arises is which water treatment pro-
cedures are adequate to reduce cyanotoxin
levels to at least below the WHO guideline
value of1.0 pg/L?
Assessment ofwater treatment procedures
has shown that most methods would result in
a reduction ofcyanobacterial toxins concentra-
tions to below acutely toxic levels as well as
below the new WHO guideline value of
1 pg/L drinking water. A completely different
situation may arise, however, during a bloom
and when water treatment procedures such as
chlorination and/or activated carbon are not
used together. Evenwhen using ozonation, the
specific situation during a bloom has to be
observed. Parameters such as organic load of
the water have to be determined and toxin
levels during the treatment steps have to be
monitored. Until issues such as ozonolysis
byproducts have been resolved, even a very
efficient method such as ozonation has to be
treated with caution. These byproducts, which
may especially be formed when an insufficient
ozone dose has been used, have been detected
in several studies, but neither their structure
nor their toxicity has been determined.
Binding to and inhibition ofprotein phos-
phatases is considered a key mechanism by
which microcystins and nodularins exhibit
their toxicity. It is therefore critical to know
which structural modification to the toxin
molecule changes the affinity to and inhibition
ofthe phosphatase. So far, neither the Adda
residue alone (74,134) nor linear nodularin- or
microcystin-precursor peptides (135) bind
protein phosphatase or bind with high IC50
values of0.5-1.0 mM and show no toxicity in
the mouse bioassay. However, it has also been
shown that substitution oftheAdda side chain
with an L-Cys residue still leads to interaction
ofthe toxin with the hydrophobic groove of
the catalytic subunit ofthe phosphatase (135).
The mechanism of tumor promotion by
microcystins and nodularins as well as the
quantitative relationships have not been satis-
factorily elucidated. It is therefore not clear if
the inhibition ofprotein phosphatase consti-
tutes the onlyormajorpathways fortoxicity or
tumor promotion. Our work has shown that
in hepatocytes, microcystin binds to proteins
other than the phosphatases (136,137). A
chronic exposure to cyanobacterial toxins
and/or to the ozonolysis byproducts should
therefore be avoided. The situation for the sax-
itoxins, anatoxin-a, anatoxin-a(s), and cylin-
drospermopsin is even less clear. A broader
scientific background onwhich risk assessment
and management steps are based should be
developed. This can lead to sound process-
based risk assessment and to the development
ofeffective procedures for water treatment
strategies aimed atspecificsituations.
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